Final results of a phase II study of sunitinib as second- line therapy in malignant pleural mesothelioma (MPM)

A. K. Nowak, M. Millward, R. J. Francis, A. Hasani, A. A. van der Schaaf, T. Seguard, A. W. Musk, M. J. Byrne

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Number of pages1
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 20 May 2010
Externally publishedYes

Cite this